Baxdela (Melinta Therapeutics, Inc)
Welcome to the PulseAid listing for the Baxdela drug offered from Melinta Therapeutics, Inc. This Fluoroquinolone Antibacterial [EPC],Fluoroquinolones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Melinta Therapeutics, Inc |
| NON-PROPRIETARY NAME: | delafloxacin meglumine |
| SUBSTANCE NAME: | DELAFLOXACIN MEGLUMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Fluoroquinolone Antibacterial [EPC],Fluoroquinolones [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-06-19 |
| END MARKETING DATE: | 0000-00-00 |
Baxdela HUMAN PRESCRIPTION DRUG Details:
| Item Description | Baxdela from Melinta Therapeutics, Inc |
| LABELER NAME: | Melinta Therapeutics, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/10.5mL) |
| START MARKETING DATE: | 2017-06-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70842-102_597ed98e-272e-4003-88f3-57c6a9481af3 |
| PRODUCT NDC: | 70842-102 |
| APPLICATION NUMBER: | NDA208611 |
Other DELAFLOXACIN MEGLUMINE Pharmaceutical Manufacturers / Labelers:
